1. Bounthavong M, Okamoto MP.

Decision analysis model evaluating

the cost-effectiveness of risperidone, olanzapine and haloperidol in
the treatment of schizophrenia. Journal of Evaluation Clinical
Practice. 2007; 13: 453-460.

2. Honer WG, Thornton AE, Chen EY, Chan RK, Wong JO, Bergmann
A, et al. Clozapine Alone versus Clozapine and Risperidone with
Refractory Schizophrenia. The New England Journal of Medicine.
2006; 354 : 472-82.

3. Remington G, Agid O, Foussias G, Hahn M, Rao N, Sinyor M.
Clozapins Role in the Treatment of First-Episode Schizophrenia. Am
J Psychiatry. 2013; 170 : 146-151.

4. PS Chue, Heeg B, Buskens E, Hout B. Modelling the impact of
compliance on th costs and effects of long-acting Risperidone in
Canada. Pharmacoeconomics. 2005; 23(Suppl. 1): 62-74.

5. Verhey FR, Verkaaik M, Lousberg R. Olanzapin versus Haloperidol
in the treatment of agitation in elderly patients with dementia : results
of a randomized controlled double blind. Dement Geriatr Cogn
Disord. 2006; 21: 1-8. doi: 10.1159/000089136.

6. Chaves KM, Blanco AS, Ribeiro SB, Soares LA, Guerra GC, Alves
MS, et al. Quality of life and adverse effects of olanzapine versus
risperidon therapy in patients with schizophrenia. Psychiatr Q. 2013;
84: 125-135. doi: 10.1007/s11126-012-9233-3.

7. Riedel M, Schwarz MJ, Strassnig M, Spellman L, Arends AM,
Weber K, et al. Risperidone plasma level, clinical response and side-
effects. Eur Arch Psychiatry Clin Neurosci. 2005; 255: 261-268. doi:
10.1007/s00406-004-0556-4.

8. Kontaxakis VP, Ferentinos PP, Kontaxaki BJ, Paplos KG, Pappa DA,
Christodolou GN. Risperidone augmentation of clozapine. Eur Arch
Psychiatry Clin Neurosci. 2006; 256: 350-355. doi: 10.1007/s00406-
006-0643-9.

9. Weiner E, Conley RR, Ball MP, Feldman S, Gold JM, Kelly DL, et
al. Adjunctive Risperidone for partially responsive people with
schizophernia treated with clozapine. Neuropsychopharmacology.
2010; 35: 2274-2283. doi: 10.1038/npp.2010.101.

10. Santos AQ, Bobermin LD, Tonial RP, Junior VB, Riesgo R, Gottfried
C. Effects of atypical (risperidone) and typical (haloperidol)
antipsychotic agents on astroglial functions. Eur Arch Psychiatry Clin
Neurosci. 2010; 260: 475-481. doi: 10.1007/s00406-009-0095-0.

11. Schooler N, Rabinowitz J, Emsley R, Harvey PD, Kopala L, et al.
Risperidone and haloperidol in first-episode psychosis: A long-term
randomized trial. The American Journal of Psychiatry. 2005; 162(5):
947-953.